- Home
- GNFT vs TEAF Comparison
GNFT vs TEAF Comparison
Compare GNFT & TEAF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GNFT
- TEAF
- Stock Information
- Founded
- GNFT 1999
- TEAF 2017
- Country
- GNFT France
- TEAF United States
- Employees
- GNFT N/A
- TEAF N/A
- Industry
- GNFT Biotechnology: Biological Products (No Diagnostic Substances)
- TEAF Trusts Except Educational Religious and Charitable
- Sector
- GNFT Health Care
- TEAF Finance
- Exchange
- GNFT Nasdaq
- TEAF Nasdaq
- Market Cap
- GNFT 186.3M
- TEAF 163.0M
- IPO Year
- GNFT 2019
- TEAF N/A
- Fundamental
- Price
- GNFT $3.75
- TEAF $12.16
- Analyst Decision
- GNFT Strong Buy
- TEAF
- Analyst Count
- GNFT 1
- TEAF 0
- Target Price
- GNFT $13.00
- TEAF N/A
- AVG Volume (30 Days)
- GNFT 3.8K
- TEAF 56.1K
- Earning Date
- GNFT 04-24-2025
- TEAF 01-01-0001
- Dividend Yield
- GNFT N/A
- TEAF 9.20%
- EPS Growth
- GNFT N/A
- TEAF N/A
- EPS
- GNFT 0.03
- TEAF N/A
- Revenue
- GNFT $73,187,701.00
- TEAF N/A
- Revenue This Year
- GNFT $15.98
- TEAF N/A
- Revenue Next Year
- GNFT N/A
- TEAF N/A
- P/E Ratio
- GNFT $120.71
- TEAF N/A
- Revenue Growth
- GNFT 105.01
- TEAF N/A
- 52 Week Low
- GNFT $2.55
- TEAF $11.11
- 52 Week High
- GNFT $6.42
- TEAF $13.30
- Technical
- Relative Strength Index (RSI)
- GNFT 44.52
- TEAF 61.64
- Support Level
- GNFT $3.44
- TEAF $11.99
- Resistance Level
- GNFT $3.81
- TEAF $12.31
- Average True Range (ATR)
- GNFT 0.17
- TEAF 0.13
- MACD
- GNFT -0.00
- TEAF -0.00
- Stochastic Oscillator
- GNFT 56.65
- TEAF 67.88
About GNFT GENFIT S.A.
Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products. It has one segment the research and development of medicines and diagnostic solutions, the marketing of which depends on the success of the clinical development phase.
About TEAF Ecofin Sustainable and Social Impact Term Fund
Tortoise Essential Assets Income Term is a USA-based non-diversified, closed-end management investment company. Its investment objective is to provide common shareholders with a high level of total return with an emphasis on current distributions.